Acadia Pharmaceuticals, Inc. stock is traded under the ticker #ACAD. Below you can review Acadia Pharmaceuticals, Inc. stock performance in the past 12 months up to November 2025

Total visits to Acadia Pharmaceuticals, Inc.'s top domains

Understand Acadia Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

acadia-pharm.com--

See more with Sales Intelligence

Avg. visit duration in Acadia Pharmaceuticals, Inc.'s top domains

Analyze Acadia Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

acadia-pharm.com--

See more with Sales Intelligence

Avg. pageviews on Acadia Pharmaceuticals, Inc.'s top domains

See how Acadia Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

acadia-pharm.com--

See more with Sales Intelligence

Acadia Pharmaceuticals, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

arenapharm.comCompany NameArena Pharmaceuticals, Inc.Employees201 - 500HQUnited States, California, San DiegoAnnual revenue> $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Acadia Pharmaceuticals, Inc.

These are the website technologies, by industry, used by Acadia Pharmaceuticals, Inc. top domains

Payment & Currencies (21)

PayPal

Widget (5)

Twemoji

Recruitment (3)

Greenhouse

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Acadia Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsACADIA Pharmaceuticals Inc. launches magnolia's guide.Acadia Pharmaceuticals announces launch of magnolia's guide to adventuring: A groundbreaking Documentary series aiming to raise disease awareness and redefine perceptions of Rett syndrome.

NewsACADIA Pharmaceuticals Inc. hired Kevin R. Oliver as Senior Vice President, Chief Business Officer on Jul 10th '23.Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today the appointment of Dr. Kevin R. Oliver as Senior Vice President, Chief Business Officer, effective July 10, 2023.

NewsACADIA Pharmaceuticals Inc. launches DAYBUE.Acadia Pharmaceuticals Inc. (Nasdaq: ACAD ) today announced that DAYBUE™ (trofinetide) is now available for the treatment of Rett syndrome in adult and pediatric patients two years of age and older in the United States.